Penetration of Antibacterials into Bone: Pharmacokinetic, Pharmacodynamic and Bioanalytical Considerations

By Landersdorfer Cornelia B.  

Clinical Pharmacokinetics, Vol. 48, Iss. 2, 2009-01 ,pp. : 89-124

Adis International

Access to resources Recommend Favorite

Predicting Plutonium Decorporation Efficacy after Intravenous Administration of DTPA Formulations: Study of Pharmacokinetic–Pharmacodynamic Relationships in Rats

By Phan Guillaume   Gall Béatrice   Deverre Jean-Robert   Fattal Elias   Bénech Henri  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2030-2035

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill Kinetics: The Minimum Inhibitory Concentration versus Stationary Concentration

By Johan W. Mouton  

Clinical Pharmacokinetics, Vol. 44, Iss. 2, 2005-01 ,pp. : 201-210

Adis International

Access to resources Recommend Favorite

A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis

By Cremers Serge   Sparidans Rolf   den Hartigh Jan   Hamdy Neveen   Vermeij Pieter   Papapoulos Socrates  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 12, 2002-02 ,pp. : 883-890

Springer Publishing Company

Access to resources Recommend Favorite

A comparative pharmacokinetic and pharmacodynamic study of FSK0808 versus reference filgrastim after repeated subcutaneous administration in healthy Japanese men

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 99-104

John Wiley & Sons Inc

Access to resources Recommend Favorite